Cheshire, CT, United States of America

Shirong Zhu

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Cheshire, CT (US) (2003 - 2013)
  • Wallingford, CT (US) (2018)

Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shirong Zhu

Introduction

Shirong Zhu is a prominent inventor based in Cheshire, CT, USA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of nine patents to his name, Zhu's work has the potential to impact the treatment of various viral infections.

Latest Patents

Among his latest patents, Zhu has developed inhibitors of human immunodeficiency virus (HIV) replication. These compounds, including pharmaceutically acceptable salts, offer new methods for treating HIV infection. Additionally, he has created piperazine analogs as broad-spectrum influenza antivirals. This compound is designed to prevent and treat influenza virus infections, showcasing his innovative approach to combating viral diseases.

Career Highlights

Zhu has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antiviral therapies.

Collaborations

Throughout his career, Zhu has collaborated with talented individuals such as Samuel Gerritz and Shuhao Shi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.

Conclusion

Shirong Zhu's contributions to antiviral research and his impressive portfolio of patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…